Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Clinical trial NCT00071539 · COMPLETED

Trial details

NCT number: NCT00071539
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme

Start date: 2003-10-01
Primary completion: 2006-01-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.